Vir Biotechnology Inc
VIR
$10.61-6.11%
End of day · as of Oct 14, 2026, 7:30 AM ET
Mkt cap
$1.45B
EV/Sales
17.8
P/E ratio
N/A
FY2025 Revenue
$68.56M
EPS (TTM)
$-1.77
Gross Margin (FY2025)
99.96%
Profit Margin (FY2025)
-638.87%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported VIR revenue for 2025-12-31 was $68.6M. Net income was -$438.0M. Revenue was down 7.6% from 2024-12-31 to 2025-12-31. VIR currently screens at market cap $1.45B.
Use this VIR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VIR income, balance, and cash tables.
Vir Biotechnology Inc (VIR) is a biotechnology company in the Healthcare sector.
Latest cached Vir Biotechnology Inc (VIR) revenue for Dec 31, 2025 was $68.6M. Net income was -$438.0M. Statements: https://lician.com/financials/vir
Vir Biotechnology Inc (VIR) market capitalization is $1.45B on the latest cached snapshot.
Vir Biotechnology Inc (VIR) cached previous close $11.30; day range $10.61 – $11.21; volume 1,782,694. Session quote: https://lician.com/quote/vir
Vir Biotechnology Inc (VIR) latest cached earnings event is "VIR earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VIR filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/vir